Results for tag: "Paget Disease Drug"

The Paget Disease Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. Paget Disease is a chronic bone disorder that causes bones to become enlarged, weakened, and misshapen. Treatment for Paget Disease typically involves medications that reduce bone turnover and pain. Commonly prescribed drugs include bisphosphonates, calcitonin, and denosumab. Bisphosphonates are the most commonly prescribed drugs for Paget Disease, as they reduce bone turnover and pain. Calcitonin is a hormone that helps regulate calcium levels in the body, and denosumab is a monoclonal antibody that helps reduce bone turnover. Companies in the Paget Disease Drug market include Amgen, Novartis, Merck, and Sanofi. Amgen produces denosumab, while Novartis produces calcitonin. Merck produces a variety of bisphosphonates, and Sanofi produces a variety of drugs for Paget Disease. Show Less Read more